Clinical trial / 2015
A modified portfolio diet reduced LDL cholesterol and improved endothelial function in diabetic patients after bypass surgery.
Thirty patients with type II diabetes 6 weeks post-bypass surgery received counseling on a Modified Portfolio Diet (MPD) including low fat, viscous fibers, soy protein, and almonds, while 7 patients with no diet therapy served as time controls. Consumption of the MPD led to a 19% relative reduction in LDL cholesterol (1.9 ± 0.8 vs 1.6 ± 0.6 mmol/L, p < 0.001) with no change in HDL cholesterol, and homocysteine levels dropped (10.1 ± 2.7 vs 7.9 ± 4 μmol/L, p = 0.006). Flow-mediated dilatation increased from 3.8 ± 3.8% to 6.5 ± 3.6% (p = 0.004) in treated patients while remaining constant in controls (p = 0.6), and endothelial progenitor cell numbers increased significantly (p < 0.02). Time controls showed no significant changes across these measures.
- Study type
- Controlled trial
- Who was studied
- 37 patients with type II diabetes 6 weeks post-bypass surgery (30 diet, 7 controls)
- What was measured
- Lipid profiles, endothelial function, markers of glycemic control, oxidative stress, and inflammation
THE PAPER
A modified portfolio diet complements medical management to reduce cardiovascular risk factors in diabetic patients with coronary artery disease.
Keith M, Kuliszewski MA, Liao C, Peeva V, Ahmed M, Tran S, Sorokin K, Jenkins DJ, Errett L, Leong-Poi H. Clin Nutr, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.